AYTU BIOPHARMA DL -0001

AY20 - F
Overview
Safety score
Dividends
Fundamentals
Add to watchlist

Add to calculator

Compare stock
AYTU BIOPHARMA DL -0001
AY20
-
F
Overview
Safety score
Dividends
Fundamentals

Overview

About stock

Health care
Sector
Drug Manufacturers-Specialty & Generic
Industry

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency.

The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021.

Similar stocks

Based on sector and market capitalization

Report issue